Why This Trader Says Johnson & Johnson Stock Could Hit $300 In 2022
From consumer health to medtech to pharmaceuticals, the latest stock I'm analyzing is a brand name you will be no stranger to, particularly due to its COVID-19 efforts.
This company's heritage spans over 130 years, boasting trailblazing scientists and innovation that has been at the forefront of safeguarding global public health.